Allergy
Alternative Medicine
Arthritis
Back Pain
Cancer
Cholesterol
Current Controversies
Dental
Dermatology
Diabetes
Endocrine Disorders
ENT-ear,nose and throat
Exercise/Rehabilitation
Eye care
FDA Warnings
Gastroenterology
General Medicine
Geriatrics
Heart Disease
Heart Healthy Cooking
Hematology
Hypertension
Infectious Disease
JAMA REPORT
Kidney Disease
Live Cases
Lung Disease
Men's Health
Mental Health
Neurologic Disease
Obesity
Orthopedics
Pediatrics
Plastic Surgery
Podiatry
Pregnancy
Rheumatology
Sexual Health
Stroke
Vascular Disease
Women's Health
JAMA Report: Dr Steven Nissen, a cardiologist at the Cleveland Clinic, presents a study reported in JAMA that a new wieght loss drug may help patients with coronary artery disease. The drug, Rimonabant, is used in Europe, but not yet approved in the United States for weight loss. Although further studies are necessary, this study did show some benefit in patients with heart disease.
JAMA Report: A new study looked at high dose vitamins and Alzheimer's disease. The study did show that the high dose vitamins did lower homocysteine levels, which is associated with Alzheimer's disease. However, having the lower levels of homocysteine did not tranlate into slowing of the disease progression in Alzheimers.
In a new study in JAMA it was found that ginko biloba, a commonly used supplement, did not prevent onset of dementia. Dr. Steven Dekosky, the Dean of Medicine at the Univ. of Virginia, presents the study.
JAMA Report: THe womens health initiative was a major study which was halted after researchers found increased health risks in patients taking hormone replacement therapy. Now a new study in JAMA shows that the risk on breast cancer continues 3 years after stopping the medications.